Show simple item record

dc.creatorMorton, D.J.
dc.date.accessioned2016-09-27T12:48:59Z
dc.date.accessioned2019-05-28T14:36:24Z
dc.date.available2016-09-27T12:48:59Z
dc.date.available2019-05-28T14:36:24Z
dc.date.created2016-09-27T12:48:59Z
dc.date.issued1986-01
dc.identifierMorton, D. J. (1986). Comparison of In vitro bioavailability of proprietary propranolol preparations. Central African Journal of Medicine, 32 (1), 23-24.
dc.identifier0008-9176
dc.identifierhttp://hdl.handle.net/10646/2813
dc.identifier.urihttp://zdhr.uz.ac.zw/xmlui/handle/123456789/1202
dc.description.abstractDissolution rate studies were conducted to compare the release rate of propranolol from two proprietary preparations. Propranolol was released at a faster rate from Rexigen* when compared to Inderal* which suggests that plasma levels of the drug would be higher in patients taking the former preparation. Both preparations showed satisfactory dissolution but problems may be encountered if a patient stabilized on one brand were to change to the other.
dc.languageen_ZW
dc.publisherUniversity of Zimbabwe, College of Health Sciences
dc.subjectPropranolol
dc.subjecthypertension
dc.subjectcardiac arrhythmias
dc.titleComparison of In Vitro bioavailability of proprietary propranolol preparations
dc.typeArticle


Files in this item

FilesSizeFormatView
Morton_Comparison_of_In_Vitro_Bioavailability.pdf88.56Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record